Life Sciences
Unlock 2026 Commercial Growth Intelligence
April 7, 2026 | 11:00 am ET | Virtual
Join a virtual roundtable where Alexander Group’s Life Sciences experts reveal the latest findings from the 2026 Sales Pulse Survey, the industry’s annual benchmark for growth expectations, commercial investments, AI adoption and revenue operations maturity.
As 2026 commercial execution begins, leaders are reassessing priorities, investments and productivity levers. This session equips leaders with data‑backed insights on growth goals, sales expense trends, headcount plans, go-to-market (GTM) investments, AI enablement and the shifting expectations for commercial teams across pharma, pharma services and life sciences tools.
Who Should Attend:
C-suite executives and senior commercial leaders across life sciences, biotech, pharma, pharma services and life sciences tools, including SVPs and VPs of commercial, revenue, sales, marketing, service, RevOps and strategy.
By attending, you’ll gain clarity on:
- 2026 Revenue Growth Outlook: How leaders are setting their targets for the year.
- Commercial Investment Priorities: Where organizations plan to increase or decrease spending across sales, marketing, service and headcount.
- AI Adoption Patterns: How executives are enabling AI, ML and GenAI across marketing, sales, service and RevOps.
- Top 2026 Strategic Levers: Where leaders are placing their bets: new channels, pricing models, geographic expansion, productivity initiatives and more.
- Benchmarking Against Your Peers: Understand how your organization compares across growth strategies, productivity priorities and technology investments.
Speakers: Craig Ackerman and Sean Higgins
Seats are limited to foster candid discussion. Please register with your corporate email. We’ll confirm attendance within 24 hours.
We look forward to seeing you at the roundtable!